Roth Capital Markets analyst Bill Kirk reiterated a “Buy” rating on Curaleaf Holdings (Curaleaf Holdings Stock Quote, Chart, News, Analysts, Financials TSX:CURA) on Jan. 22 and maintained his $4.00 price target after the company pre-announced a fourth-quarter revenue beat and confirmed it is exiting its U.S. hemp-THC business. Wakefield, Mass.–based Curaleaf is a multinational, vertically […]
Beacon Securities analyst Russell Stanley maintained a “Buy” rating and C$5.00 price target on Curaleaf Holdings (Curaleaf Holdings Stock Quote, Chart, News, Analysts, Financials TSX:CURA) in a Jan. 20 report, after the company released preliminary fourth-quarter results that tracked ahead of guidance saying that the preliminary disclosure “should be viewed positively.” Curaleaf reported preliminary Q4 […]
Share
Tweet
Share
